Search results
Results from the WOW.Com Content Network
The PSA test is used to monitor men after surgery or radiation therapy for prostate cancer to see if their cancer has recurred (come back). If a man’s PSA level begins to rise after prostate cancer treatment, it may be the first sign of a recurrence.
Learn about prostate changes and symptoms that are not cancer, plus risk factors and treatment for prostatitis, enlarged prostate (BPH), prostate cancer. Talk with your doctor about prostate cancer screening tests (DRE, PSA).
PSA. A protein made by the prostate gland and found in the blood. PSA blood levels may be higher than normal in men who have prostate cancer, benign prostatic hyperplasia (BPH), or infection or inflammation of the prostate gland. Also called prostate-specific antigen.
PSA is a substance made by the prostate that may be found in higher than normal amounts in the blood of men who have prostate cancer. PSA levels may also be high in men who have an infection or inflammation of the prostate or BPH (an enlarged, but noncancerous, prostate).
La prueba del PSA se usa para medir la concentración del PSA en la sangre. Para esta prueba, se envía una muestra de sangre a un laboratorio para su análisis. Los resultados en general se indican en nanogramos de PSA por mililitro de sangre (ng/ml).
Prostate cancer is the second most common cancer among men in the United States. Prostate cancer is most common in older men. In the United States, about one out of every eight men will be diagnosed with prostate cancer. Most men diagnosed with prostate cancer do not die of it.
They may order lab tests, imaging tests (scans), or other tests or procedures. You may also need a biopsy, which is often the only way to tell for sure if you have cancer. This page covers tests that are often used to help diagnose cancer. Depending on your symptoms, you may have other tests, too.
A rapid increase in prostate-specific antigen (PSA) levels is not grounds for automatically recommending a prostate biopsy, according to a study published online February 24, 2011, in the Journal of the National Cancer Institute.
Smaller studies have strongly suggested that PSMA PET-CT is better at detecting metastases in men with localized prostate cancer, Dr. Pomper said, so more definitive answers from larger studies have been anxiously awaited.
Prostate cancer screening with the prostate-specific antigen (PSA) test or digital rectal exams has not been shown to reduce prostate cancer deaths. Get detailed information about prostate cancer screening, including potential benefits and harms, in this summary for clinicians.